Detail of "5251-34-3"

CAS Number:
5251-34-3
Name:
Cloprednol
Molecular Structure:
Formula:
C₂₁H₂₅ClO₅
Molecular Weight:
392.876
Synonyms:
Pregna-1,4,6-triene-3,20-dione,6-chloro-11β,17,21-trihydroxy- (7CI,8CI);Cloprednole;Cloradryn;Novacort;RS 4691;Synestan;
EINECS:
226-052-6
Density:
1.4 g/cm³
Boiling Point:
600.3 °C at 760 mmHg
Flash Point:
316.9 °C

Supplier Location
Supplier Location
- China (Mainland)(3)
Business Type
Business Type
- Lab/Research institutions(1)
- Manufacturers(0)
- Trading Company(2)
Certificates
Certificates
- ISO (0)
- Production License (0)

Display：

cloprednol

Supplier:TRUST&WE CO.,Ltd. [ China (Mainland)]

620 Integral
620

Tel:+86-021-61551611

Address:No. 317, 219 Nong, Gao Muqiao Road, Zhangjiang Hightech. Park, Pudong, Shanghai

Chloroprednisone

305 Integral
305

Tel:+86-21-57590133

Address:Qianqiao economic park, Fengxian, Shanghai, China

600 Integral
600

Tel:86-22-23709100, 23709200

Address:Hi-Tech Building A, Room507-511,Huatian Road,Huayuan Industry Park, Tianjin 300384, China

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Treating diseases by daily administration of 6-chloro-11b,17a,21-trihydroxypregna-1,4,6-triene-3,20-dione: Treating diseases by daily administration of 6-chloro-11b,17a,21-trihydroxypregna-1,4,6-triene-3,20-dione. Segre, Eugene J. (Syntex (U.S.A.), Inc., USA). U.S. US 4051241 27 Sep 1977, 6 pp. (English). (United States of America). CODEN: USXXAM. CLASS: IC: A61K031-56. NCL: 424243000. APPLICATION: US 75-557137 10 Mar 1975. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) Allelgic, dermatol., and rheumatic diseases in mammals are treated with I [5251-34-3]. I has a plasma cortisol half-life of ~120 min which is relatively short compared to other steroids, thus lacking the deleteriousside effects assocd. with interference with hypothalamic-pituitary-adrenal axis function during long term corticosteroid administration. Also adverse metabolic effects, namely, loss of N and Ca are minimized when I, as compared to prednisolone, is administered. Tablets were prepd., each contg. 12.5 mg I/tablet. Capsules were also prepd.